Wnc Dermatological Associates, Pa

CLIA Laboratory Citation Details

3
Total Citations
5
Total Deficiencyies
3
Unique D-Tags
CMS Certification Number 34D0689244
Address 281 Mcdowell Street, Asheville, NC, 28803
City Asheville
State NC
Zip Code28803
Phone(828) 252-5676

Citation History (3 surveys)

Survey - July 22, 2026

Survey Type: Standard

Survey Event ID: 72Q311

Deficiency Tags: D5417 D5477

Summary:

Summary Statement of Deficiencies D5417 TEST SYSTEMS, EQUIPMENT, INSTRUMENTS, REAGENT CFR(s): 493.1252(d) (d) Reagents, solutions, culture media, control materials, calibration materials, and other supplies must not be used when they have exceeded their expiration date, have deteriorated, or are of substandard quality. This STANDARD is not met as evidenced by: Based on review of manufacturer's instructions, observation, and interview with the laboratory director 7/22/26, the laboratory failed to discard Dermatophyte Test Medium (DTM) slants that exceeded their expiration date. Findings: Review of the Hardy Diagnostics Dermatophyte Test Medium (DTM) Instructions for Use revealed "...STORAGE AND SHELF LIFE ... The product may be used and tested up to the expiration date on the product label and incubated for the recommended incubation times ..." During a tour of the laboratory at approximately 10:40 a.m., the surveyor observed 5 Hardy Diagnostics DTM slants (lot number 662353, expiration date 12/16 /25) in the refrigerator, available for use. During interview at approximately 10:40 a. m., the laboratory director confirmed the DTM slants were expired and discarded them. D5477 CONTROL PROCEDURES CFR(s): 493.1256(e)(4)(g) (e)(4) Before, or concurrent with the initial use-- (e)(4)(i) Check each batch of media for sterility if sterility is required for testing; (e)(4)(ii) Check each batch of media for its ability to support growth and, as appropriate, select or inhibit specific organisms or produce a biochemical response; and (e)(4)(iii) Document the physical characteristics of the media when compromised and report any deterioration in the media to the manufacturer. Statement of Deficiencies (X1) Provider/Supplier/CLIA Identification Number (X3) Date Survey Completed Name of Provider or Supplier Street Address, City, State -- 1 of 2 -- This STANDARD is not met as evidenced by: Based on review of manufacturer's instructions, review of 2025 and 2026 patient fungal culture logs, and interview with the laboratory director 7/22/26, the laboratory failed to check each lot number of DTM for growth and appropriate biochemical response. Approximately 17 patients were tested 11/3/25 - 7/22/26 using DTM that was not checked for growth and appropriate biochemical response. Findings: Review of the Hardy Diagnostics Dermatophyte Test Medium (DTM) Instructions for Use revealed "USER QUALITY CONTROL End users of commercially prepared culture media should perform QC testing in accordance with applicable government regulatory agencies, and in compliance with accreditation requirements. Hardy Diagnostics recommends end users check for signs of contamination and deterioration and, if dictated by laboratory quality control procedures or regulation, perform quality control testing to demonstrate growth or a positive reaction and to demonstrate inhibition or a negative reaction, if applicable. ..." Review of 2025 and 2026 patient fungal culture logs revealed the laboratory had used two lot numbers of DTM since the previous survey on 10/7/25: 1. Lot number 658018, expiration 11/2/25 - the laboratory documented the performance of a check for media quality and acceptability on receipt, but had not performed any checks for growth and appropriate biochemical response. 2. Lot number 662353, expiration 12/16/25 - the laboratory had not performed a check for media quality and acceptability on receipt and had not performed any checks for growth and appropriate biochemical response. During interview at approximately 10:50 a.m., the laboratory director confirmed that the laboratory had not checked each lot number of DTM for growth and appropriate response. He stated the DTM manufacturer stopped providing a quality control kit with each shipment of media and they had not been able to find another source for the quality control kit. -- 2 of 2 --

πŸ”’ Unlock Deficiency Summary

Get full access to the detailed deficiency summary for this facility

One-time payment β€’ Lifetime access

Survey - October 7, 2025

Survey Type: Standard

Survey Event ID: O9ZI11

Deficiency Tags: D5411 D5411

Summary:

Summary Statement of Deficiencies D5411 TEST SYSTEMS, EQUIPMENT, INSTRUMENTS, REAGENT CFR(s): 493.1252(a) (a) Test systems must be selected by the laboratory. The testing must be performed following the manufacturer's instructions and in a manner that provides test results within the laboratory's stated performance specifications for each test system as determined under 493.1253. This STANDARD is not met as evidenced by: Based on review of manufacturer's instructions and review of 2024 and 2025 patient dermatophyte test medium (DTM) culture logs 10/7/25, the laboratory failed to follow manufacturer's instructions for incubation and result interpretation. Findings: Review of the Hardy Diagnostics Dermatophyte Test Medium Instructions for Use revealed "... PROCEDURE ... Incubate media at room temperature (15-30 degrees C.), aerobically, for up to fourteen days. ... INTERPRETATION OF RESULTS ... Media should be examined daily for up to fourteen (14) days. ... LIMITATIONS ... False - positive reactions may result, if interpretations are made beyond 14 days of incubation. An alkaline reaction will eventually be produced by most non- dermatophytic fungi that are capable of growing on this medium. ..." Review of 2024 and 2025 patient DTM culture logs revealed 18 patient cultures performed 1/1/24 - 10 /7/25 were incubated longer than the manufacturer's specified 14 days. Examples: 1. Patient A - DTM set up 3/11/24, result reported 4/3/24 (23 days); 2. Patient B - DTM set up 5/17/24, result reported 7/24/24 (68 days); 3. Patient C - DTM set up 9/13/24, result reported 10/15/24 (32 days); 4. Patient D - DTM set up 11/12/24, notation on log stated "11/26 - allow 2 more weeks", result reported 12/11/24 (29 days); 5. Patient E - DTM set up 1/24/25, result reported 2/18/25 (25 days); 6. Patient F - DTM set up 7 /3/25, result reported 7/30/25 (27 days). Statement of Deficiencies (X1) Provider/Supplier/CLIA Identification Number (X3) Date Survey Completed Name of Provider or Supplier Street Address, City, State -- 1 of 1 --

πŸ”’ Unlock Deficiency Summary

Get full access to the detailed deficiency summary for this facility

One-time payment β€’ Lifetime access

Survey - March 23, 2021

Survey Type: Standard

Survey Event ID: POVV11

Deficiency Tags: D5417

Summary:

Summary Statement of Deficiencies D5417 TEST SYSTEMS, EQUIPMENT, INSTRUMENTS, REAGENT CFR(s): 493.1252(d) Reagents, solutions, culture media, control materials, calibration materials, and other supplies must not be used when they have exceeded their expiration date, have deteriorated, or are of substandard quality. This STANDARD is not met as evidenced by: Based on observation, review of laboratory's procedures, and interview with the laboratory director 3/23/21, the laboratory failed to discard KOH(potassium hydroxide) and Chlorazol Black fungal stain reagents that had exceeded their expiration dates. Findings: During tour of the laboratory at approximately 1:05pm 3/23 /21, the surveyor observed two bottles of KOH (lot # K15C13, expiration date: 12/31 /18) and one bottle of Chlorazol Black( lot # K19C91, expiration date: 12/31/20) located by the microscope, that were available for use. The laboratory's procedure, Quality Assurance Program under Quality control states, "All test materials(KOH, saline, etc) are stored as directed by the manufacturer. All outdated materials are discarded." At approximately 1:15pm, the laboratory director confirmed the KOH and Chlorazol Black reagents were expired. He stated the laboratory does not perform the testing very often and they had not realized the reagents were expired. Statement of Deficiencies (X1) Provider/Supplier/CLIA Identification Number (X3) Date Survey Completed Name of Provider or Supplier Street Address, City, State -- 1 of 1 --

πŸ”’ Unlock Deficiency Summary

Get full access to the detailed deficiency summary for this facility

One-time payment β€’ Lifetime access